Contemporary outcomes of chronic total occlusion percutaneous coronary intervention in Europe: the ERCTO registry.

Mario Iannaccone, On Behalf Of The Euro Cto Investigators, Iskander Atmowihardjo, Nicolaus Reifart, Meruzhan Saghatelyan, Andrew Ladwiniec, Nicolaus Boudou, Alexander Avran, Mohamed Ayoub, Gerald S Werner, Kambis Mashayekhi, Carlo Di Mario, Eugenio La Scala, Gabriele L Gasparini, Roberto Diletti, Sudhir Rathore, Alfredo R Galassi, Alexander Bufe, Michael Behnes, George Sianos, Sevket Gorgulu, Giuseppe Vadalà, Laura Maniscalco, Pierfrancesco Agostoni, Roberto Garbo, Omer Goktekin

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2024;20(3):e185-e197

PMID: 38343371

Abstract

BACKGROUND

Percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) have reached high procedural success rates thanks to dedicated equipment, evolving techniques, and worldwide adoption of state-of-the-art crossing algorithms.

AIMS

We report the contemporary results of CTO PCIs performed by a large European community of experienced interventionalists. Furthermore, we investigated the impact of different risk factors for procedural major adverse cardiac and cerebrovascular events (MACCE) and trends of employment of specific devices like dual lumen microcatheters, guiding catheter extensions, intravascular ultrasound and calcium-modifying tools.

METHODS

We evaluated data from 8,673 CTO PCIs included in the European Registry of Chronic Total Occlusion (ERCTO) between January 2021 and October 2022.

RESULTS

The overall technical success rate was 89.1% and was higher in antegrade as compared with retrograde cases (92.8% vs 79.3%; p<0.001). Compared with antegrade procedures, retrograde procedures had a higher complexity of attempted lesions (Japanese CTO [J-CTO] score: 3.0±1.0 vs 1.9±1.2; p<0.001), a higher procedural and in-hospital MACCE rate (3.1% vs 1.2%; p<0.018) and a higher perforation rate with and without tamponade (1.5% vs 0.4% and 8.3% vs 2.1%, respectively; p<0.001). As compared with mid-volume operators, high-volume operators had a higher technical success rate in antegrade and retrograde procedures (93.4% vs 91.2% and 81.5% vs 69.0%, respectively; p<0.001), and had a lower MACCE rate (1.47% vs 2.41%; p<0.001) despite a higher mean complexity of the attempted lesions (J-CTO score: 2.42±1.28 vs 2.15±1.27; p<0.001).

CONCLUSIONS

The adoption of different recanalisation techniques, operator experience and the use of specific devices have contributed to a high procedural success rate despite the high complexity of the lesions documented in the ERCTO.

Address: Division of Cardiology, University Hospital "P. Giaccone", Palermo, Italy.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.; Medizinische Klinik I, Klinikum Darmstadt GmbH, Darmstadt, Germany.; Al Qassimi Hospital, Sharjah, United Arab Emirates.; Clinique St Augustin, Bordeaux, France.; Maria Pia Hospital, GVM Care & Research, Turin, Italy.; Helios Klinikum Krefeld, University Witten/Herdecke, Witten, Germany.; Centre Hospitalier de Valenciennes, Valenciennes, France.; Humanitas Research Hospital, IRCSS, Rozzano, Italy.; Polyclinique Les Fleurs, Ollioules, France.; Department of Cardiovascular Sciences, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.; Erebouni Medical Center, Yerevan, Armenia and Nork-Marash Medical Center (NMMC), Yerevan, Armenia.; Memorial Bahçelievler Hospital, Istanbul, Turkey.; Department of Cardiology, Acibadem University Istanbul, Istanbul, Turkey.; Goethe-Universität Frankfurt, Frankfurt am Main, Germany.; Hartcentrum, Ziekenhuis Netwerk Antwerpen (ZNA) Middelheim, Antwerp, Belgium.; Frimley Park Hospital, NHS Foundation Trust, Camberley, United Kingdom.; University Heart Center NRW, Bad Oeynhausen, Germany.; University Medical Centre Mannheim, Mannheim, Germany.; Department of Cardiology and Angiology, DRK Kliniken Berlin Köpenick, Berlin, Germany.; San Giovanni Bosco Hospital, ASL Città Torino, Turin, Italy.; Interventional Cardiology, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands.; Department of Clinical & Experimental Medicine, Structural Interventional Cardiology Division, Careggi University Hospital, Florence, Italy.; Department of Cardiology and Angiology, University Heart Center, University Freiburg, Freiburg, Germany.; Department of Internal Medicine and Cardiology, Heart Center Lahr, Lahr, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.